Apo-Go® (Apomorphine Hydrochloride Hemihydrate)

Apo-Go® is a medication containing Apomorphine Hydrochloride Hemihydrate, used for subcutaneous administration. It is commonly associated with the management of certain movement disorders. This product is manufactured by Stada Arzneimittel AG in the EU.

Apo-Go® is primarily used for the treatment of movement disorders, particularly those related to Parkinson's disease. It works by stimulating dopamine receptors in the brain, which can help improve motor function. Patients often wonder, 'What is Apo-Go® used for?' and the answer lies in its ability to manage symptoms such as tremors, stiffness, and slow movement.

Common effects of Apo-Go® may include nausea, dizziness, and drowsiness. Some users may also experience hallucinations or confusion. It is important to monitor for any unusual side effects and consult a healthcare provider if they occur.

Apo-Go® should be handled with care, ensuring proper storage and administration techniques. It is crucial to follow the prescribed guidelines for subcutaneous use to minimize the risk of infection or other complications. Always use sterile needles and follow proper disposal procedures.

Apo-Go® may interact with other medications, including those that affect dopamine levels or blood pressure. Alcohol and certain antidepressants can also influence its effects. It is advisable to discuss all current medications with a healthcare provider to avoid potential interactions.